Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print March 5, 2003.
Biol Reprod 2003, 10.1095/biolreprod.102.011577
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/1/269    most recent
biolreprod.102.011577v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.
Agricola
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.
BIOLOGY OF REPRODUCTION 69, 269–277 (2003)
DOI: 10.1095/biolreprod.102.011577
© 2003 by the Society for the Study of Reproduction, Inc.


Ovary

Expression of Hyaluronan Synthases and Corresponding Hyaluronan Receptors Is Differentially Regulated During Oocyte Maturation in Cattle1

Martin Schoenfelder, and Ralf Einspanier2

Institute of Physiology, Technical University of Munich, D-85354 Freising, Germany


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In response to the gonadotropin surge, the compact cumulus-oocyte complex (COC) undergoes expansion by synthesis of the mucopolysaccharide hyaluronan (HA) accompanying oocyte maturation. The objective of the present study was to quantify mRNA transcripts of the HA synthase (HAS) 1, HAS2, and HAS3 and the HA-receptors CD44 and RHAMM (receptor for HA-mediated motility). Additionally, we determined the histological localization of HA and its receptor, CD44, in maturing bovine COCs and cultured granulosa cells (GCs). Full-length transcript of bovine HAS2 and a part of the bovine RHAMM sequence has been made available. Real-time reverse transcriptase-polymerase chain reaction was used for individual mRNA expressions of bovine COCs in comparison to follicular GC gonadotropin treatment. Localization of CD44 and HA were done by immunohistochemistry and biotinylated HA-binding protein, respectively. Gonadotropins caused a rapid, 120-fold increase of HAS2 mRNA, whereas a delayed, 2-fold up-regulation of HAS3 mRNA was observed. The HAS1 transcripts were barely detected. Expression of CD44 mRNA greatly increased during in vitro maturation of COCs, indicating an important role when compared to an unchanged, steady-state RHAMM expression. As a consequence, HA was locally enriched after COC expansion, but only limited change was observed in the GCs. In cultured GCs, HAS2 expression was stimulated through FSH application, followed by the effective treatments of FSH+LH and LH. Treatment with LH induced the highest increase of the CD44 receptor, followed by FSH and FSH+LH treatments. These results suggest that HAS2 is mainly responsible for rapid HA synthesis in bovine COCs and GCs. In bovine COCs, the transcriptional up-regulation of both HAS2 and the receptor CD44 appear to be important prerequisites for initiating HA-mediated effects during final oocyte development and sperm-egg interaction.

cumulus cells, gene regulation, granulosa cells, oocyte development


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
During the development of ovarian follicles, the granulosa cells (GCs) form a multilayered epithelium surrounding the maturing oocyte. At the end of follicle growth, the GCs differentiate into two subpopulations: the oocyte-attached cumulus cells, and the mural GCs. Several hours after the endogenous LH surge, the cumulus-oocyte complex (COC) undergoes expansion in cattle [1] and other species [2, 3]. This process is thought to be stimulated by FSH or epidermal growth factor [47]. One of the principal components of the expanded COC is the glycosaminoglycan (GAG) hyaluronan (HA), which is composed of repetitive disaccharides of D-glucuronate and N-acetylglucosamine. This large, linear mucopolysaccharide (2000–25 000 disaccharide units) contributes to tissue homeostasis [8] and biomechanics [9]. To support these complex interactions, different soluble proteins appear to be involved [10]. Some of these HA-binding molecules are of cumulus cell origin [11, 12] and have proposed effects on COC functionality. The resulting spongiform COC matrix may facilitate the extrusion of the oocyte at ovulation and prevent the dispersion of the surrounding cells. Furthermore, HA is supposed to play a key role during fertilization and sperm capacitation [13]. In contrast to the other intracellular-produced GAGs, HA is synthesized at the cell membrane by HA synthases (HAS) [14], which extrude the growing polymer into the extracellular space. In mammals, the HAS family consists of three known isoenzymes (HAS1, HAS2, and HAS3) [15, 16].

During COC expansion in mammalian species, HAS2 [3, 17] was suggested to synthesize the huge amount of HA found in ovarian follicles [18]. Recently, receptors for HA have been identified and include the transmembrane receptors CD44 (named by clusters of differentiation) and RHAMM (receptor for HA-mediated motility). The glycoprotein CD44, probably the most common HA receptor, is characterized by a variety of isoforms caused by alternative splicing and posttranslational modifications [19]. This receptor is responsible for cell-to-cell and cell-to-extracellular matrix (ECM) interactions [20], inhibition of apoptosis [21], endocytosis of HA [22], augmentation of tumor cell motility and metastasis [23], and stimulation of lymphocytes [24]. In contrast, little information is available concerning the regulation of CD44 gene expression, though recent studies indicate that CD44 may influence fertility and quality of human oocytes [25].

The other known HA receptor, RHAMM, possesses two potential HA-binding sites [26]. Interactions between HA and RHAMM could activate protein kinases that modulate cellular behavior. Known to promote cell movement, RHAMM is located both in the cell as well as at the cell surface [27]. Furthermore, the HA receptor may be involved in wound healing [28], migration of smooth muscle cells [29], and modulation of ciliary beating of the airway epithelial cells [30].

The aim of the present study was to characterize the expression profiles of HAS1, HAS2, and HAS3 as well as the corresponding receptors, CD44 and RHAMM, during in vitro maturation (IVM) of bovine COCs. By use of real-time reverse transcriptase-polymerase chain reaction (RT-PCR), the mRNA transcripts of HAS1, HAS2, HAS3, CD44, RHAMM, ubiquitin, and 18S rRNA were relatively quantified. Additionally, immunohistochemistry of CD44 and localization of HA by biotinylated HA-binding protein (bHABP) were used to describe the HA system in ovarian cumulus and GCs when under the influence of gonadotropin.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Sampling and Culture Conditions

Noncystic bovine ovaries were collected, irrespective of stage of the estrous cycle, at a local abattoir and transported at 37°C in sterile Ringer solution to the laboratory within 1 h. Immediately, COCs were recovered by aspiration and sorted out for grade 1 COCs with a compact and multilayered cumulus oophorus as well as homogeneous ooplasm [31]. To reduce estrous cycle-dependent effects, groups of 10 COCs underwent IVM [32, 33]. The COCs were cultured in 400 µl of bicarbonate-buffered modified Parker medium (MPM, pH 7.2) supplemented with 10% (w/w) fetal calf serum (Seromed; Biochrom KG, Berlin, Germany). The MPM was composed of 15.0 g/L of Medium 199 (M-2520; Sigma, Taufkirchen, Germany), 2.2 mg/ml of sodium bicarbonate (S-5761; Sigma), 50 µg/ml of gentamicin (Selectevet; Germany), 0.23 mg/ml of pyruvate (15220; Serva, Heidelberg, Germany), 50 µg/ml of ascorbic acid (A-4034; Sigma), 0.55 mg/ml of calcium lactate (Merck, Darmstadt, Germany), and 0.01 IU/ml of bovine FSH (NIH B1 activity) as well as 0.01 IU/ml of LH (NIH LH B10; Sioux Biochemicals, Sioux Center, IA).

Granulosa cells were recovered by rinsing antral follicles with PBS (0.24 g/L of KH2PO4, 8.0 g/L of NaCl, 0.2 g/L of KCl, and 1.44 g/L of Na2HPO·2H2O; pH 7.4) using a 10-ml, single-use syringe (Braun, Melsungen, Germany) connected to a 20-gauge needle (Sterican; Braun); washing three times in culture medium; and seeding into 12-well uncoated tissue-culture plates (4 x 105 cells per 2-ml well). To reduce contamination of atretic GCs, only small follicles up to 8 mm were punctured. Potential influence of simultaneously extracted COCs was prevented by sorting out the GC cultures for oocytes. Gonadotropin stimulation with FSH, LH, or both in combination started 1.5 days after seeding (onset), when all GCs were attached to the bottom and proliferating. The FSH and LH were each used at final concentrations of 0.01 IU, as indicated above. Sampling was carried out at the onset, after 4 h, and after 24 h by removing culture medium and cell lysis for total RNA extraction directly in culture dishes.

RNA Extraction and RT-PCR

For total RNA extraction, all culture media were removed. Before cell lysis, all cultured COCs and GCs were washed twice in sterile PBS and put through RNA extraction performed by spin columns (NucleoSpin RNA II; Macherey & Nagel, Düren, Germany) including DNase1 digestion (Macherey & Nagel) to reduce contaminating DNA. The RNA integrity was verified by optical density (OD) 260/OD280-nm absorption (Biophotometer; Eppendorff, Hamburg, Germany). Total RNA (COC, 200 ng; GC, 500 ng) was reverse transcribed with 200 IU of MMLV-Reverse Transcriptase (Promega, Madison, WI) using 2.5 µM random hexamer primers (Gibco BRL, Carlsbad, CA) and 0.5 mM dNTPs (Roche Diagnostics, Heidelberg, Germany) as described previously [33].

The following primer sets were selected based on published data as indicated. Optimal annealing temperatures (AT) were established in a gradient cycler (Mastercycler; Eppendorff) and tested for quantification temperature (QT) by a melting-point analysis in the LightCycler (Roche): 18S rRNA, forward 5'-AAG TCT TTG GGT TCC GGG-3', reverse 5'-GGA CAT CTA AGG GCA TCA CA-3' (EMBL, AF176811; product, 365 base pairs (bp); AT, 60°C; QT, 82°C); ubiquitin, forward 5'-AGA TCC AGG ATA AGG AAG GCA T-3', reverse 5prime;-GCT CCA CCT CCA GGG TGA T-3' (EMBL, Z18245; product, 198 bp; AT, 60°C; QT, 85°C), HAS1, forward 5'-GGT ACA ACC AGA AGT TCC TGG G-3', reverse 5'-CGG AAG TAC GAC TTG GAC CAG-3' (EMBL, AB017803; product, 184 bp; AT, 55°C; QT, 79°C); HAS2, forward 5'-GGM TGT GTC CAG TGC ATT AGC GGA C-3', reverse 5'-CAG CAC TCG GTT CGT TAG RTG CCT G-3' (EMBL, U54804; product, 144 bp; AT, 68°C; QT, 80°C); HAS3, forward 5'-ACA GGT TTC TTC CCC TTC TTC C-3', reverse 5'-GCG ACA TGA AGA TCA TCT CTG C-3' (EMBL, AJ293889; product, 166 bp; AT, 60°C; QT, 84°C); HA-receptor CD44, forward 5'-TAT AAC CTG CCG ATA TGC AGG-3', reverse 5'-CAG CAC AGA TGG AAT TGG G-3' (EMBL, X62881; product, 221 bp; AT, 64°C; QT, 83°C); and HA-receptor RHAMM, forward 5'-TGT TGA ATG AAC ATG GTG CAG CTC-3', reverse 5'-CCT TAG AAG GGT CAA AGT GTT TGA T-3' (EMBL, AF310973; product, 249 bp; AT, 61°C; QT, 77°C). To verify specificity of each gene amplification, PCR products were isolated and sequenced (TopLab, Martinsried, Germany).

Quantitative Real-Time PCR

For each sample, a standard 10-µl real-time PCR reaction mix (Roche) was prepared containing the following components: 1 µl of LightCycler mix, 4 mM MgCl2, 0.4 mM primers, and sample cDNA (COC, 0.33 ng/µl; GC, 0.83 ng/µl). The QTs were set below the individual melting peak of each PCR product. For specific gene amplification, a standard protocol of 50 cycles was used in the LightCycler: After initial polymerase activation at 95°C for 10 min, primer-specific amplification and quantification cycles were run at AT and QT as indicated above. To evaluate specific amplification, a final melting curve was created (60–99°C) under continuous fluorescent measurement.

Relative quantification was determined using sample crossing points analyzed with LightCycler software 3.5 (Roche) by the second derivative maximum method.

PCR Efficiency and Relative Quantification

PCR efficiency The PCR efficiency (E) of each primer set was determined within distinct detection ranges (2.7 pg to 8.33 ng of cDNA) and calculated according to the following equation [34]:

(1)
From resulting standard curves (n = 3), PCR efficiency, slope (s), and regression (r) were determined as follows: for 18S rRNA, E = 1.95, s = -3.436, and r = -0.997; for ubiquitin, E = 2.00, s = -3.320, and r = -0.994; for HAS1, E = 1.81, s = -3.856, and r = -0.991; for HAS2, E = 1.81, s = -3.874, and r = -0.993; for HAS3, E = 1.82, s = -3.841, and r = -0.995; for CD44, E = 2.00, s = -3.323, and r = -0.996; and for RHAMM, E = 1.98, s = -3.453, and r = -0.995.

Relative quantification A mathematical model adopted from the LightCycler software package [35] served to calculate the relative differences between groups. Relative expression ratios were calculated by the following equation:

(2)
where CPcontrol is the crossing point of the untreated group at the onset of the experiment and CPsample is the crossing point of the treatment group.

To evaluate the efficiencies of the preceding RT reaction, unregulated reference genes are suggested as control [36]. Therefore, all cDNA samples were compared to endogenous standards. Because of its highly balanced expression (P = 0.092), ubiquitin and 18S rRNA served as the main housekeeping genes in our system. To ensure reproducibility and accuracy of real-time PCR, assay precision was confirmed using ubiquitin PCR within one LightCycler run (n = 3) or at three different days using different batches of LightCycler premixes showing an intraassay variation of 6.05% and an interassay variation of 8.40%.

Full-Length cDNA Sequencing

Full-length cDNA sequencing of the bovine HAS2 was performed using the SMART-RACE cDNA-Kit (Clontech, Palo Alto, CA) introducing total RNA of bovine COCs. One microgram of RNA and 200 IU of MMLV-Reverse Transcriptase were used for first-strand synthesis in the 5'- as well as 3'-direction. Resulting cDNA libraries were subsequently used for amplification of specific PCR products by introducing the described HAS2 primers in a thermal cycler (Master Gradient Cycler; Eppendorff) performing 25 cycles of denaturation at 94°C for 5 sec, annealing at 68°C for 10 sec, and elongation at 72°C for 2 min and 30 sec. The PCR products were sequenced commercially (TopLab).

Statistical Analysis

One-way ANOVA was used to test the effects of LH, FSH, and FSH+LH application. Differences between groups (n = 6) were identified by least significant difference Student t-test (P < 0.05). Analyses were performed with SAS release 8.01 (SAS, Inc., Cary, NC). Raw data are presented as the crossing point (mean ± SD) and the variation quotient (in %). Results were depicted by the calculated expression ratios according to the control group.

Histological Localization of HA and Immunodetection of CD44

Cultured bovine COCs and ovary were embedded in TissueTek (Miles, Inc., Torrance, CA) and shock-frozen in liquid nitrogen. Serial cross-sections (COC: thickness, 14 µm; ovary: thickness, 7 µm) were performed using a cryotome (HM 505E; Microm, Walldorf, Germany) and mounted on preheated (37°C) HistoBound glass slides (Marienfeld). The GCs were grown and treated directly on sterilized glass slides provided with flexiPERM chambers (Vivascience AG, Germany). Before specific staining, all cryosections as well as cultured GCs were air-dried for 30 min at 37°C and fixed with ethanol for 5 min at room temperature at -30°C for HA localization or with 3.7% formaldehyde in PBS for 15 min at room temperature for CD44 immunodetection.

For HA localization, all tissues were incubated for 30 min with 5 ng/ml of bHABP (catalog no. 385911; Calbiochem, San Diego, CA) diluted in PBS. Unbound bHABP was removed by washing twice in PBS. To detect bound bHABP, slides were treated for 30 min with a streptavidin fluorescein conjugate (SAF; 1 µg/ml, catalog no. 189734; Calbiochem), washed twice in PBS, counterstained for 5 min with propidium iodide in PBS (2.5 µg/ml), and mounted in antifading solution Citiflour AF1 (Agar Scientific, Essex, U.K.). Negative controls were performed either without bHABP or without SAF.

Immunolocalization of bovine HA-receptor CD44 was accomplished by using rat-anti-porcine CD44 immunoglobulin (Ig) G (1:100 dilution; SM488, lot 130900; DPC Biermann, Bad Nauheim, Germany) as first antibody and horseradish peroxidase (HRP)-labeled goat-anti-rat IgG (1:200 dilution; R1378HRP, lot 6563; DPC Biermann) for visualization by diaminobenzidine (DAB; D-5905; Sigma). After fixation in formaldehyde, samples were washed twice in PBS and incubated for 30 min in 1% H2O2 to block endogenous peroxidases. Background was reduced by treatment with 10% normal goat serum for 30 min. First-antibody incubation was done overnight, followed by three washing steps in PBS and incubation with HRP-labeled goat-anti-rat IgG for 1 h. Specific staining of CD44 were visualized by 0.05% DAB in 0.01% H2O2. Additionally, samples were counterstained by Mayers Haemalaune, dehydrated with graded alcohols, and embedded in Eukitt (Kindler, Freiburg, Germany). Specificity of the immunodetection was proved by several negative controls: 1) replacement of the first antibody, 2) replacement of secondary antibody, and 3) incubation with DAB alone to show efficiency of blocking endogenous peroxidases. All samples were visualized with a Axioscope microscope (Zeiss, Jena, Germany) and documented by digital imaging (Zeiss AxioCam MR with AxioVision software) or color slides (Kodak Elite 100; Eastman Kodak, Rochester, NY).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The PCR-based amplifications of the bovine COC mRNA, obtained during IVM, detected discrete components of the HA system, including enzymes and receptors (Fig. 1). Different signal intensities were identified for HAS2, HAS3, CD44, and RHAMM. Figure 1 indicates that HAS1 mRNA was hardly detected when amplified for 35 PCR cycles. The four more-abundant members of the HA system were subsequently detected and quantified by real-time RT-PCR.



View larger version (86K):
[in this window]
[in a new window]
 
FIG. 1. Messenger RNA expression (one of six experiments) of selected genes during 24-h IVM of bovine COC detected by a conventional RT-PCR. Housekeeping genes: 18S rRNA (18S) and ubiquitin (ubq); target genes: HAS1, HAS2, HAS3, and HA receptors (CD44 and RHAMM). Bovine follicular cell RNA served as the positive control. Specific amplicons were separated by gel electrophoresis

Sequencing of the bovine HAS2 mRNA by use of rapid amplification of cDNA ends technology lead to an mRNA of 2946 bases possessing the 5' untranslated area and the entire 3' untranslated region containing a putative polyadenylation signal (AATAAA) at base 2888, leading further into the poly-A-tail. An open reading frame was identified between bases 545 and 2201 encoding a 552-amino acid protein (63 kDa). This HAS2 cDNA sequence has been submitted to a nucleic acid database to permit public access (EMBL, BTA004951). To our knowledge, it is the first description of the complete bovine HAS2 mRNA sequence derived from bovine COC RNA, enabling further transcript characterization in cattle. The deduced open reading frame showed high homologies to known HAS2 cDNA as well as to deduced protein sequences of other species (cDNA homology, 93.6% human, 90.7% rat, and 88.9% mouse; protein homology, 97%–98%).

Furthermore, a functional PCR setup amplifying bovine RHAMM transcripts was introduced (Fig. 1). Sequencing of this cDNA provided a new partial sequence of this bovine HA-receptor type, including two potential HA-binding sites (EMBL, AJ439694) with high homologies to other RHAMM sequences (cDNA homology, 98% sheep, 89% human, and 82% rat).

HA Synthases

In both cumulus as well as GCs, HAS2 showed the most prominent increase in mRNA expression after gonadotropin treatment (FSH+LH in COCs and LH in GCs). In COCs, HAS2 transcripts reached the highest levels (120-fold) within 4 h (Fig. 2A) and decreased thereafter, reaching a plateau at 60-fold higher when compared to the experimental onset (P < 0.001). In GCs, the HAS2 elevation (Fig. 3A) was highest under FSH (5.5-fold, P = 0.04), followed by FSH+LH in combination (3.5-fold, P = 0.003) and then LH (2.6-fold, P = 0.05). After 24 h, HAS2 transcripts returned to or dropped below the baseline level.



View larger version (37K):
[in this window]
[in a new window]
 
FIG. 2. Expression ratio during 24-h IVM detected for HAS2 (A), HAS3 (B), CD44 (C), and RHAMM (D) in bovine COC. Statistically significant differences are indicated by letters (P < 0.05). Means of crossing points (CP mean), SD of crossing points (SD), and variation quotient (VQ) are depicted in the bottom charts



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 3. Expression ratios during 24-h culture of bovine GCs in relation to the experimental onset for HAS2 (A), HAS3 (B), CD44 (C), and RHAMM (D). Treatments: control (MPM199 [MPM] + fetal calf serum [FCS]), LH (MPM+FCS+0.01 IU/ml of LH), FSH (MPM+FCS+0.01 IU/ml of FSH), and FSH+LH (MPM+FCS+0.01 IU/ml each of FSH and LH). Dashed line represent expression level (100%) at the onset (0 h). Statistical analysis were done by one-way ANOVA (least significant difference test), whereby differences between groups (P < 0.05) are indicated by letters and between onset and groups by an asterisk. Mean of crossing point (CP mean), SD of crossing point (SD), and variation quotient (VQ) are depicted in the bottom charts

Although HAS3 increased, if not as much as HAS2, significant alteration of HAS3 transcripts was detected after 12- and 24-h IVM in COCs (Fig. 2B). The relative concentration at the onset of IVM and 4 h later (indicated by low crossing points) as well as the increase after 12 h in HAS3-specific mRNA (2-fold, P = 0.003) was always below the height found for HAS2. In contrast, cultured GCs always showed a significant decline of HAS3 transcripts within the first 4 h compared to the onset (Fig. 3B). Regardless of gonadotropin treatment, the HAS3 expression was adjusted to the lowest levels at the end of each experiment after 24 h.

In bovine COCs as well as in GCs, HAS1 mRNA was not detectable with the real-time RT-PCR system (2 pg of cDNA). The validity of these primers was demonstrated using whole ovarian follicle mRNA (Fig. 1).

HA-Receptors CD44 and RHAMM

Within the first 4 h of COC maturation, very low mRNA quantities of the HA-receptor CD44 were present (Fig. 2C). After 12 h of IVM, CD44 expression increased more than 100-fold (P = 0.001) and stayed high until the end of maturation (24 h, P = 0.047). In GCs, response to both gonadotropins was detected, but at a lower level (Fig. 3C). In these cells, LH induced the highest increase (2.2-fold, P = 0.019) within the first hours, followed by FSH (1.9-fold, P = 0.047). In addition, FSH showed a more prolonged stimulus on CD44 expression after 24 h (P = 0.028). However, no effect was observed when both gonadotropins were supplemented simultaneously (4 h, P = 0.546; 24 h, P = 0.496).

The PCR results for RHAMM indicated that its mRNA is detectable at all stages of IVM in COCs (Fig. 2D) as well as during GC culture (Fig. 3D). The initial expression of RHAMM decreased until the end of COC maturation and reached significant differences compared to the control after 4 and 24 h of IVM. In contrast, during the first hours, the RHAMM mRNA levels in GCs stayed unchanged, but it reached significantly higher levels in all groups after 24 h. Neither FSH, LH, or their combination provoked significant alterations compared to the untreated control.

Localization of HA-Receptor CD44 in the Ovary, COCs, and Cultured GCs

Serial cross-sections of the whole bovine ovary showed a distinct staining for immunoreactive CD44 in small antral follicles (Fig. 4A). Specific staining could be detected for the theca interna as well as for the theca externa. However, no specific localization for CD44 was observed in mural GCs or in COCs of immature follicles (Fig. 4A).



View larger version (148K):
[in this window]
[in a new window]
 
FIG. 4. Histological detection of CD44 by specific antibody. Specific localizations were detected by a brown DAB-chromophore. Nuclei were counterstained with Mayers Haemalaune. A) Cryosection of an early antral follicle. B) Cryosection of COC 24 h after IVM. C) Cryosection of corpus luteum. D) Cultured GCs (arrows depict CD44-specific immunoreaction)

In sections obtained from matured bovine COCs with an expanded cumulus, specific staining for CD44 was observed only for several cumulus cells (Fig. 4B). In contrast, cells of both corpora lutea (Fig. 4C) and cultured mural GCs (Fig. 4D) were positive for the HA-receptor CD44. Furthermore, in GC cultures, an irregular staining was observed (Fig. 4D, arrows).

Localization of HA in COCs and GCs

In histological cross-sections of COCs, it could be shown that the cumulus forms a compact and multilayered envelope around the oocyte (Fig. 5A). At the onset of IVM, all cumulus cells were tightly attached to each other, and only a faint HA-specific staining could be detected in the extracellular space. After 24 h of IVM (Fig. 5B), an increase of HA, indicated by the green fluorescence, could be observed. Most of the cumulus cells were dispersed from the oocyte but were anchored in a large coat of HA. Only a single-cell layer, the corona, was still attached to the oocyte. All the controls remained free of unspecific staining (data not shown). In cultured GCs, HA was hardly detectable at the beginning of the experiment (Fig. 5C), but after 4 h, sporadic signals specific for HA became visible (Fig. 5D). In GC cultures grown in medium supplemented with both gonadotropins, increased and cloud-like, HA-specific fluorescence was observed (Fig. 5E). However, 24 h after gonadotropin stimulation, all cultured GCs appeared to be nearly depleted of cell-bound HA molecules (Fig. 5F).



View larger version (133K):
[in this window]
[in a new window]
 
FIG. 5. Histochemical localization of HA by bHABP conjugated with SAF and counterstained with propidium iodide. A and B) Serial cross-sections of COC at the beginning of IVM (A) and after 24 h of cultivation (B). CF) GCs grown on glass slides. Untreated control culture is shown at the onset (C) and after 4 h without gonadotropins (D). Also shown are GCs treated with FSH+LH after 4 h (E) and after 24 h (F)


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, a functional HA-synthesizing and -binding system was detected during IVM of bovine oocytes. Of the three identified mammalian HA-producing enzymes, only two, HAS2 and HAS3, were observed. Their obvious regulation throughout oocyte maturation may be mediated by gonadotropins. After determining the missing gene information for the bovine HAS2 and RHAMM, first transcript quantifications could detect a distinct and immediate amplification of HAS2, HAS3, and CD44 within the first hours of IVM by use of real-time RT-PCR.

These findings were supported by the excessive local accumulation of HA, shown using histological techniques, that matched the increased enzyme transcription. These rapid changes indicate extensive alterations of the microenvironment during bovine IVM, leading to cumulus expansion, probably under peripheral hormonal control. Ubiquitous HA is known to influence major cellular events, such as cell migration and proliferation [37], and might be an important polymer during final oocyte development and fertilization [13]. Compared to HAS3, HAS2 is the most abundantly expressed HA-synthesizing enzyme during bovine COC expansion, as has been reported in mouse cumulus cells as well [38]. However, in contrast to the rapid mRNA expression of HAS2 in the cow, recent reports by Kimura et al. [3] concerning porcine IVM showed a significant increase of HAS2, but not until 24 h. Additionally, HAS3 mRNA was located exclusively in porcine oocytes and was lowered by substitution with gonadotropins. These lower amounts of porcine HAS3 expression are comparable to the present bovine system when LH and FSH were added to the maturation medium. However, the lower transcript concentration does not exclude HAS3 from also being important for HA production during cumulus expansion [16] when considering the diverse processing characteristics of these enzymes, as shown earlier [39]. The HAS3 possesses intrinsically higher catalytic activity than other HAS enzymes, and the chain length of HA molecules synthesized by HAS3 is shorter when compared to HAS2-generated polymers. Low-molecular-weight HA will directly influence the expression of cytokines and cell shape in eosinophils [40], but the proportion as well as the effect of the different HA length classes in the bovine cumulus is unknown. The immediate response of HAS2 to gonadotropins indicates its local importance, but the influence of the later, much-less-expressed HAS3 has to be established in the bovine COC relative to different functions of the resulting polymer. Independent of biomechanical effects during ovulation, HA could transmit signals through binding to receptor proteins and, potentially, influence cell functions and properties in a paracrine manner [41].

Although little is known about regulation of the HA-receptors CD44 and RHAMM in reproductive tissue, the few experiments that have been conducted suggest that CD44 plays an important role during human oocyte maturation [25] and prevents apoptosis in human GCs [21]. The CD44 protein has been found by immohistochemistry in a variety of mammalian epithelial cells, including oviduct, uterus, and vagina [42]. Such observations suggest a local communication between the cumulus-derived HA and the HA receptors on the reproductive epithelium (e.g., the oviduct). Cycle-dependent regulations of CD44 in the human tissues have been described with increased levels during the uterine secretory phase, indicating a possible steroid influence [43]. Conversely, our results suggest an endocrine influence on the mRNA expression of the HA-receptor CD44. Although GCs produced steroid hormones under FSH or LH application, the production of progesterone and estradiol lagged behind the initial increase of CD44 mRNA at 4 h [44]. Therefore, the major influence on CD44 induction in GCs is likely based on gonadotropins rather than on steroid hormones. In contrast to the lack of CD44 modulation in GCs, with simultaneous treatment of LH and FSH the same conditions led to a significant increase of CD44 mRNA transcripts during COC maturation. Hence, our results suggest both an endocrine as well as a paracrine regulation of CD44 through gonadotropins and, probably, oocyte factors, respectively. A few so-called oocyte-derived factors (e.g., growth and differentiation factor 9) may be potential modulators for the essential interplay between the oocyte and the surrounding somatic cells [45]. Additionally, the altered expression pattern of HAS3 in oocyte-surrounding cumulus cells when compared to the GCs indicates especially the oocyte's feasible influence. Although RHAMM was unregulated under gonadotropins, possible functions of this HA receptor in the bovine reproductive tract could be important, because basic expression levels during IVM were found to be compared to CD44 expression. The RHAMM may mediate movement and attachment of human cumulus cells [46], or it could modulate ciliary beating of oviduct epithelia, as described for the respiratory system [30]. Recent work discovered CD44 as the essential HA receptor throughout development of the preimplantation human embryo [47] and during trophoblast implantation [48]. Further investigations will be necessary to elucidate the detailed functions of both receptor types in the bovine reproductive system.

Our in vitro results indicate that a balance of FSH and LH is capable of modulating the main components of the HA system in bovine follicular cells. These data support an influence of the endogenous gonadotropin surge before ovulation and, subsequently, stimulating HAS2 expression within 24 h in native follicular GCs [49]. The common bovine IVM system appears to be comparable to normal physiological situations leading to fully mature COCs. An exogenous application of HA during bovine IVM showed beneficial effects on both IVM and in vitro production of embryos [50]. Additionally, Saito et al. [18] postulate that the concentration of HA in the follicular fluid could be used as an indicator to estimate oocyte fertilization capacity.

Previously described effects of HA surrounding the oocyte have indicated that it could serve as a protective shield as well as a reservoir for different growth factors. Glycosaminoglycans are negatively charged compounds and, therefore, bind unspecifically to many other substances, including growth factors. The interactions between GAGs and cytokines are one of the important mechanisms underlying communication processes between cells that are mediated by secreted and locally acting factors. Various studies have shown that quite a few cytokines are associated with the ECM by polysaccharide-binding motives [51]. For example, vascular endothelial growth factor protein has been found attached in increasing amounts at the bovine COC during final maturation [32], and such HA-rich oocyte microspheres may serve as a pool for such potent cytokines. Rapid remodeling of the ECM of COCs may trigger cell function through a possible cleavage of cytokines from that matrix. Still another mechanism of HA action together with bound cytokines could alter cell dynamics through intracellular uptake of HA via CD44-mediated incorporation [22]. A mucosal host defense has been proposed based on HA protecting cells from ciliary clearance in the lung [52]. This may draw future attention to interesting interactions between the cumulus and the oviduct after ovulation of the COCs.

In summary, our findings assign HAS2 and the corresponding receptor, CD44, a major role during final bovine oocyte maturation facilitating cumulus expansion. Interestingly, CD44 appeared to be differentially expressed in bovine cumulus in contrast to GCs: LH and FSH in combination induced an altered reaction in GCs. Considering such a diverse response, oocyte-derived local factors likely play a role in regulating the CD44 expression during IVM independent of endocrine signals. The results of investigations with HA components indicate a complex, local, and fine-tuned system during final oocyte maturation in the cow. These findings may further complete our understanding of the complex network of circulating hormones, local growth factors, and ECM components enabling optimal development of the oocyte that leads to reproductive success. Furthermore, the growing knowledge of such essential physiological processes supporting oocyte maturation will enable an improved understanding of assisted reproduction.


    ACKNOWLEDGMENTS
 
We thank Craig Baumrucker (Pennsylvania State University, State College, PA) for reviewing the English grammar, Stefanie Schiebe and Tamara Stelzl for technical assistance, and Rupert Bruckmayr and Michael Pfaffl for mathematical and statistical support.


    FOOTNOTES
 
1 Supported by the DFG. Back

2 Correspondence: Ralf Einspanier, Institute of Physiology, Weihenstephaner Berg 3, D-85354 Freising, Germany. FAX: 49 8161 71 4204; einspanier{at}wzw.tum.de Back

Received: 20 September 2002.

First decision: 9 October 2002.

Accepted: 19 February 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ball GD, Bellin ME, Ax RL, First NL. Glycosaminoglycans in bovine cumulus-oocyte complexes: morphology and chemistry. Mol Cell Endocrinol 1982 28:113-122[CrossRef][Medline]
  2. Salustri A, Yanagishita M, Hascall VC. Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell-oocyte complex during follicle-stimulating hormone-induced mucification. J Biol Chem 1989 264:13840-13847[Abstract/Free Full Text]
  3. Kimura N, Konno Y, Miyoshi K, Matsumoto H, Sato E. Expression of hyaluronan synthases and CD44 messenger RNAs in porcine cumulus-oocyte complexes during in vitro maturation. Biol Reprod 2002 66:707-717[Abstract/Free Full Text]
  4. Eppig JJ. FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles. Nature 1979 281:483-484[CrossRef][Medline]
  5. Downs SM, Daniel SA, Eppig JJ. Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin. J Exp Zool 1988 245:86-96[CrossRef][Medline]
  6. Khatir H, Lonergan P, Carolan C, Mermillod P. Prepubertal bovine oocyte: a negative model for studying oocyte developmental competence. Mol Reprod Dev 1996 45:231-239[CrossRef][Medline]
  7. Armstrong DT, Xia P, de Gannes G, Tekpetey FR, Khamsi F. Differential effects of insulin-like growth factor-I and follicle-stimulating hormone on proliferation and differentiation of bovine cumulus cells and granulosa cells. Biol Reprod 1996 54:331-338[Abstract]
  8. Knudson CB, Knudson W. Hyaluronan-binding proteins in development tissue homeostasis and disease. FASEB J 1993 7:1233-1241[Abstract]
  9. Scott JE, Cummings C, Brass A, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer. Biochem J 1991 274:699-705
  10. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001 12:79-87[CrossRef][Medline]
  11. Kobayashi H, Sun GW, Hirashima Y, Terao T. Identification of link protein during follicle development and cumulus cell cultures in rats. Endocrinology 1999 140:3835-3842[Abstract/Free Full Text]
  12. Chen L, Mao SJ, Larsen WJ. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-{alpha}-trypsin inhibitor family. J Biol Chem 1992 267:12380-12386[Abstract/Free Full Text]
  13. Cherr GN, Yudin AI, Li MW, Vines CA, Overstreet JW. Hyaluronic acid and the cumulus extracellular matrix induce increases in intracellular calcium in macaque sperm via the plasma membrane protein PH-20. Zygote 1999 7:211-222[CrossRef][Medline]
  14. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 1997 272:13997-14000[Free Full Text]
  15. Watanabe K, Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem 1996 271:22945-22948[Abstract/Free Full Text]
  16. Spicer AP, Olson JS, McDonald JA. Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem 1997 272:8957-8961[Abstract/Free Full Text]
  17. Salustri A, Yanagishita M, Underhill CB, Laurent TC, Hascall VC. Localization and synthesis of hyaluronic acid in the cumulus cells and mural granulosa cells of the preovulatory follicle. Dev Biol 1992 151:541-551[CrossRef][Medline]
  18. Saito H, Kaneko T, Takahashi T, Kawachiya S, Saito T, Hiroi M. Hyaluronan in follicular fluids and fertilization of oocytes. Fertil Steril 2000 74:1148-1152[CrossRef][Medline]
  19. Yu Q, Toole BP. Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia. Dev Dyn 1997 208:1-10[CrossRef][Medline]
  20. Naot D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997 71:241-319[Medline]
  21. Kaneko T, Saito H, Toya M, Satio T, Nakahara K, Hiroi M. Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet 2000 17:162-167[CrossRef][Medline]
  22. Tammi R, Rilla K, Pienimaki JP, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001 276:35111-35122[Abstract/Free Full Text]
  23. Thomas L, Byers HR, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 1992 118:971-977[Abstract/Free Full Text]
  24. Lesley J, Hyman R, English N, Catterall JB, Turner GA. CD44 in inflammation and metastasis. Glycoconj J 1997 14:611-622 Review [CrossRef][Medline]
  25. Ohta N, Saito H, Kuzumaki T, Takahashi T, Ito MM, Saito T, Nakahara K, Hiroi M. Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes. Mol Hum Reprod 1999 5:22-28[Abstract/Free Full Text]
  26. Yang B, Zhang L, Turley EA. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 1993 268:8617-8623[Abstract/Free Full Text]
  27. Toole BP. Hyaluronan in morphogenesis. J Intern Med 1997 242:35-40[CrossRef][Medline]
  28. Stevens R, Bhargava J, Powell RJ. Endothelial cells inhibit smooth muscle cell secretion of hyaluronanic acid. J Vasc Surg 1998 28:319-325[CrossRef][Medline]
  29. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 1995 95:1158-1168
  30. Lieb T, Forteza R, Salathe M. Hyaluronic acid in cultured ovine tracheal cells and its effect on ciliary beat frequency in vitro. J Aerosol Med 2000 13:231-237[Medline]
  31. Le Guienne B. Atlas of the bovine oocyte. A.E.T.E. Newsletter 1999 10:6-8
  32. Einspanier R, Schönfelder M, Müller K. Stojkovic M, Kosmann M, Wolf E, Schams D. Expression of the vascular endothelial growth factor (VEGF) system and first effects of VEGF during in vitro maturation of bovine cumulus-oocyte complexes (COC). Mol Reprod Dev 2002 62:29-36[CrossRef][Medline]
  33. Bieser B, Stojkovic M, Wolf E, Meyer H, Einspanier R. Growth factors and components for extracellular proteolysis are differentially expressed during in vitro maturation of bovine cumulus-oocyte complexes. Biol Reprod 1998 59:801-806[Abstract/Free Full Text]
  34. Rasmussen R. Quantification on the LightCycler. In: Meuer S, Wittner C, Nakagawara K (eds.), Rapid Cycle Real-Time PCR: Methods and Applications. Heidelberg: Springer Press; 2001:21–34
  35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001 29:2002-2007
  36. Marten NW, Burke EJ, Hayden JM, Straus DS. Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells. FASEB J 1994 8:538-544[Abstract]
  37. Tempel C, Gilead A, Neeman M. Hyaluronic acid as an anti-angiogenic shield in the preovulatory rat follicle. Biol Reprod 2000 63:134-140[Abstract/Free Full Text]
  38. Tirone E, D'Alessandris C, Hascall VC, Siracusa G, Salustri A. Hyaluronan synthesis by mouse cumulus cells is regulated by interactions between FSH (or EGF) and a soluble oocyte factor (or TGFß1). J Biol Chem 1997 272:4787-4794[Abstract/Free Full Text]
  39. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999 274:25085-25092[Abstract/Free Full Text]
  40. Ohkawara Y, Tamura G, Iwasaki T, Tanaka A, Kikuchi T, Shirato K. Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol 2000 23:444-451[Abstract/Free Full Text]
  41. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001 276:36770-36778[Abstract/Free Full Text]
  42. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 1989 108:1557-1565[Abstract/Free Full Text]
  43. Albers A, Thie M, Hohn HP, Denker HW. Differential expression and localization of integrins and CD44 in the membrane domains of human uterine epithelial cells during the menstrual cycle. Acta Anat 1995 153:12-19[Medline]
  44. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001 122:829-938[Abstract]
  45. Schoenfelder M, Schams D, Einspanier R. Steroidogenesis during in vitro maturation of bovine cumulus oocyte complexes and possible effects of tributyltin on granulosa cells. J Steroid Biochem Mol Biol 2003 84:297-300
  46. Kennedy S, England MA, Mills C. Human cumulus cell complexes studied in vitro by light microscopy and scanning electron microscopy. Zygote 1994 2:133-147[Medline]
  47. Aplin JD. Adhesion molecules in implantation. Rev Reprod 1997 2:84-93[Abstract]
  48. Goshen R, Ariel I, Shuster S, Hochberg A, Vlodavsky I, de Groot N, Ben-Rafael Z, Stern R. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod 1996 2:685-691[Abstract/Free Full Text]
  49. Einspanier R, Schoenfelder M. Differential expression of three hyaluronan synthases and the hyaluronan receptor CD44 during final maturation of the bovine cumulus-oocyte complex. Biol Reprod 2001 64: (suppl 1) 482[Abstract/Free Full Text]
  50. Furnus CC, de Matos DG, Martinez AG. Effect of hyaluronic acid on development of in vitro produced bovine embryos. Theriogenology 1998 49:1489-1499[CrossRef][Medline]
  51. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994 269:114-121[Abstract/Free Full Text]
  52. Forteza R, Lieb T, Aoki T, Savani RC, Conner GE, Salathe M. Hyaluronan serves a novel role in airway mucosal host defense. FASEB J 2001 15:2179-2186[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
ReproductionHome page
H M Picton, S E Harris, W Muruvi, and E L Chambers
The in vitro growth and maturation of follicles
Reproduction, December 1, 2008; 136(6): 703 - 715.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Assidi, I. Dufort, A. Ali, M. Hamel, O. Algriany, S. Dielemann, and M.-A. Sirard
Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro
Biol Reprod, August 1, 2008; 79(2): 209 - 222.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
N. Borg and M. Holland
The effect of glycosaminoglycans on rat gametes in vitro and the associated signal pathway
Reproduction, March 1, 2008; 135(3): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. P.A. van Montfoort, J. P.M. Geraedts, J. C.M. Dumoulin, A. P.M. Stassen, J. L.H. Evers, and T. A.Y. Ayoubi
Differential gene expression in cumulus cells as a prognostic indicator of embryo viability: a microarray analysis
Mol. Hum. Reprod., March 1, 2008; 14(3): 157 - 168.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. L. Russell and R. L. Robker
Molecular mechanisms of ovulation: co-ordination through the cumulus complex
Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. G Clarke, S. A Hope, S. Byers, and R. J Rodgers
Formation of ovarian follicular fluid may be due to the osmotic potential of large glycosaminoglycans and proteoglycans
Reproduction, July 1, 2006; 132(1): 119 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Stuhlmeier and C. Pollaschek
Adenovirus-mediated Gene Transfer of Mutated I{kappa}B Kinase and I{kappa}B{alpha} Reveal NF-{kappa}B-dependent as Well as NF-{kappa}B-independent Pathways of HAS1 Activation
J. Biol. Chem., December 30, 2005; 280(52): 42766 - 42773.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Ohno-Nakahara, K. Honda, K. Tanimoto, N. Tanaka, T. Doi, A. Suzuki, K. Yoneno, Y. Nakatani, M. Ueki, S. Ohno, et al.
Induction of CD44 and MMP Expression by Hyaluronidase Treatment of Articular Chondrocytes
J. Biochem., May 1, 2004; 135(5): 567 - 575.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/1/269    most recent
biolreprod.102.011577v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.
Agricola
Right arrow Articles by Schoenfelder, M.
Right arrow Articles by Einspanier, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS